ZENAS BIOPHARMA TO PARTICIPATE IN UPCOMING HEALTHCARE INVESTOR CONFERENCES

WALTHAM, Mass, 8 Nov (Bernama-GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences:

  • Guggenheim’s Inaugural Healthcare Innovation Conference on November 12, 2024, in Boston, MA
  • Jefferies London Healthcare Conference on November 19, 2024 presentation at 4:00 p.m. to 4:25 p.m. GDT, in London
  • Citi’s 2024 Global Healthcare Conference on December 3, 2024 presentation at 9:30 a.m. to 10:10 a.m. ET, in Miami, FL
  • Evercore ISI HealthCONx Conference on December 4, 2024 presentation at 1:20 p.m. to 1:40 p.m. ET, in Coral Gables, FL

Live webcasts and archived replays of the Company’s presentations at the Jefferies, Citi and Evercore conferences can be accessed under “Events and Presentations” in the Investors and Media section of the Zenas BioPharma website.

About Zenas BioPharma, Inc.

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas’ lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s mechanism of action and chronic dosing regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on X at @ZenasBioPharma and LinkedIn.

The Zenas BioPharma word mark and logos are trademarks of Zenas BioPharma, Inc. or its affiliated companies.

Investor Contact:
Matthew Osborne
Investor Relations and Corporate Communications
Matt.osborne@zenasbio.com

Media Contact:
Argot Partners
Zenas@argotpartners.com

SOURCE : Zenas BioPharma (USA) LLC

DUCK CREEK TO HELP MDA NATIONAL DEVELOPS, PROVIDES INNOVATIVE NEW SERVICES

KUALA LUMPUR, Nov 7 (Bernama) — Duck Creek Technologies has been selected by MDA National (MDAN), an Australia-wide medical defence organisation, to deliver their new policy administration, policyholder portal, billing and next-gen analytics and insights solutions.

Duck Creek’s platform will help MDAN develop and provide innovative new services, improved member self-service and enhanced data-driven risk management capabilities, allowing them to increase the support and protection offered to their growing medical practitioner member base, in turn strengthening the medical care available to communities.

“We look forward to being a strategic technology partner to MDAN as they deliver new and innovative offerings that meet and surpass the evolving needs of Australia’s medical professionals.

“Duck Creek continues to meet the needs of our partners and customers by delivering mission critical insurance SaaS technology to key medical indemnity and general insurers in Australia and the rest of the world,” said its Managing Director of APAC, Christian Erickson in a statement.

Meanwhile, MDAN Chief Executive Officer, Ian Anderson said: “Transforming our technological capability through our partnership with Duck Creek will significantly enhance our ability to deliver on our purpose of supporting and protecting members whilst promoting good medical practice, leading to a successful and sustainable future.”

Duck Creek’s cloud-based OnDemand platform will replace MDAN’s legacy system to improve the ease of doing business for both members and staff, increase speed of change, and help create a more agile and innovative service-led model.

Furthermore, Duck Creek’s solutions were preferred due to their out-of-the-box capabilities, reusable, and customisable modular architecture, user-experience led design, configurability, automation and future-proof capacity.

As the global intelligent solutions provider defining the future of the property and casualty (P&C) and general insurance industry, Duck Creek’s extensive experience serving the local and international medical indemnity markets was also a significant influencing factor.

— BERNAMA

Liangma River Enlivened With Dazzling Light Show 

KUALA LUMPUR, Nov 4 (Bernama) — The recently launched 2024 Beijing Chaoyang International Light Festival has illuminated the Liangma River Cultural and Economic Belt under the theme “Following Light, Beautiful Shadows”.

The festival featured over 50 lighting installations as well as staged over 10 entertainment and consumption events across three key areas, namely the Liangma River International Water Front with the sub-theme of “Flowing Light and Color”, Chaoyang Park (“A Light Adventure”), and Junwangfu (Mansion of Commandery Prince Shuncheng), where visitors can access these attractions either on water or on land.

Starting from the Yansha Wharf, an “AI Dancer” gracefully performs on building facades, showcasing a dance projection called “Light Dance of Blossoms”, created using artificial intelligence (AI) technology, according to a statement.

At Liangma Port, the Bogong Lock features a rich display of light and shadow effects, combining naked-eye projection, laser drawing, and mechanical movements with a strong national style.

Meanwhile, at SOLANA Wharf, the “Magical Night: Music Box” light show combines music with visual art, creating a lively atmosphere that feels like a magical stage.

The Liangma River connects the major shopping districts of Sanlitun, Yansha, and SOLANA, and is lined by nearly 10,000 high-rated shops, including five-star hotels, Michelin restaurants, cafes, tea houses, bookstores, and theatres.

This integration of leisure and culture highlights the unique characteristics of a riverside zone with interconnected commercial areas, making it Beijing’s only waterfront economic belt that gathers cultural, commercial, and tourism factors.

As a “golden business card” for Beijing’s cultural and tourism industries, the Liangma River Cultural and Economic Belt is highly favoured by residents and domestic and international visitors alike.

In the future, Chaoyang will upgrade this economic belt, introducing emerging industries and digital art activities and creating avant-garde cultural spaces and popular destinations for cultural, commercial, tourism, and sports consumption that appeal to youths and lure more international visitors to enjoy the beautiful night scenery by boat.

— BERNAMA

Medidata Unveils Bundled Solution For Oncology, Vaccine Research

KUALA LUMPUR, Nov 1 (Bernama) — Medidata, a Dassault Systèmes brand and provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research.

Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the Food and Drug Administration (FDA) guidance for patient-centred endpoints, adaptive trial designs, and trial diversity.

Both offerings combine a variety of Medidata technologies and learnings from thousands of previous trials to streamline study management for Phase II and Phase III studies in specified therapeutic areas, according to a statement.

By unifying key trial components such as real-time patient-reported outcomes and imaging management, these bundled solutions will aid sponsors by reducing trial complexity, accelerating decision-making, and improving assessments of treatment efficacy and safety.

“By making these new bundled capabilities readily available to customers, we can deliver a solution built on Medidata’s vast experience and expertise in these two important therapeutic areas.

“These bundles are designed to help customers navigate the complicated stages of these studies while advancing life-saving treatments,” said Medidata chief operating officer, Joseph Schmidt.

Medidata, with more than 25 years of oncology and vaccine experience and the largest global trial datasets, has conducted approximately 9,000 oncology studies and 750 trials in vaccines. In 2023, it was recorded that 93 per cent of oncology drug approvals went through Medidata.

The company was also on the frontlines of COVID-19, supporting hundreds of trials, including the development of one of the most effective messenger ribonucleic acid (mRNA) vaccines used to fight the virus.

Both solutions deliver a unified data ecosystem by integrating Medidata Rave EDC, Medidata eCOA, Medidata Rave Imaging, Medidata Clinical Data Studio, and Health Record Connect.

— BERNAMA

THE THIRD XIANGTAN TOURISM DEVELOPMENT CONFERENCE WAS HELD IN SHAOSHAN COUNTY

XIANGTAN, China, Nov. 1, 2024 /Xinhua-AsiaNet/–

From October 28th to 29th, the Third Xiangtan Tourism Development Conference & the Fourth Tan Business Conference were held in Shaoshan, Xiangtan city, Hunan province.

The conference innovatively combined the two major IPs of “cultural tourism” and “Tan businessmen”. Following the opening ceremony, the focus was on cultural tourism projects and industries, with a special investment promotion and project signing ceremony for the cultural tourism industry and the Xiangjiang Science City (Xiangtan) segment, effectively achieving seamless integration of cultural tourism and commerce. This Tan Business Conference facilitated the signing of 64 projects with a total investment of 15.8 billion yuan.

Xiangtan, a city with profound historical heritage and breathtaking natural scenery, is not only renowned for its abundant historical sites but also boasts numerous enchanting tourist attractions, unfolding like exquisite paintings along the banks of the Xiangjiang River.

Taking advantage of this conference as an opportunity, Xiangtan city has also launched a series of subsidiary activities, including the promotion of Xiangtan cuisine, the Shaoguan Half Marathon, the Torch Relay Run, the Youth Hiking, and other integrated cultural, tourism, and sports series events, providing guests, citizens, and tourists with a rich cultural tourism experience.

As the host of this year’s Xiangtan Tourism Development Conference, Shaoshan has been committed in recent years to deeply exploring the connotations of historical culture, developing tourism resources, injecting new vitality and energy into Xiangtan’s cultural tourism industry. From January to September this year, Shaoshan received a total of 4.2707 million tourist visits, achieving a total tourism revenue of 6.282 billion yuan.

Source: The Organizing Committee of the Third Xiangtan Tourism Development Conference

–BERNAMA